KOL Perspectives: Perception of mirikizumab in moderate-to-severe UC
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Questions topics:
› Perception of Phase II mirikizumab induction data in UC
› Perception of mirikizumab’s Phase III study in UC
› Future expectations of mirikizumab in UC
› Future expectations for mirikizumab in Crohn’s disease
Scope
› The insight briefing is based on Sociable Pharma’s analysis of primary research with our ulcerative colitis key opinion leaders (KOLs)
› In total, we conducted interviews with 10 KOLs:
– 5 Europe-based & 5 N. America-based
– Interviews performed during July 2018
> KOL data is analyzed to produce:
– Charts summarizing KOL opinions
– Chart call-outs of key information & details
– KOL quotes
– Summary of KOL reporting trends
– Insight from Sociable Pharma's analysts
Key Highlights
All but one KOL noted that 200mg was the optimal dose for mirikizumab in UC, while flagging the lack of dose response
Endoscopic & histological healing highlighted by most KOLs as suitable secondary endpoints in mirikizumab’s ongoing Phase III UC trial
KOLs could not differentiate the clinical profile of mirikizumab in UC from other anti-IL-23s, and were divided over its dosing regimen
Reasons to Buy
Combines Qualitative & semi-quantitative insight from key opinion leaders on mirikizumab in moderate-to-severe UC
Includes insight & recommendations from our disease-specific healthcare analysts
Utilizes independent expert viewpoints to validate the impact of new clinical data & emerging trends on management of UC
Provides cost-effective support for your advisory boards, with topics acting as a catalyst for further expert discussion
Takeda
Pfizer
Janssen
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.